33214 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 15
14:19 UTC
|
WFG
West Fraser Timber
|
↑ Upgrade | Daryl Swetlishoff ★★★☆☆ #991 | Market Perform→ Outperform | $75.00→ $85.00+13.3% |
|
Sep 15
14:19 UTC
|
LKNCY
Luckin Coffee
|
↑ Upgrade | firm only | Outperform | |
|
Sep 15
13:19 UTC
|
THO
Thor Industries
|
◎ Target | Tristan Thomas-Martin not yet tracked | Outperform | $110.00→ $95.00-13.6% |
|
Sep 15
13:19 UTC
|
TALO
Talos Energy
|
◎ Target | Tim Rezvan ★★★★★ #55 | Overweight | $21.00→ $23.00+9.5% |
|
Sep 15
13:19 UTC
|
SM
SM Energy
|
◎ Target | Tim Rezvan ★★★★★ #55 | Overweight | $39.00→ $46.00+17.9% |
|
Sep 15
13:19 UTC
|
PR
Permian Resources
|
◎ Target | Tim Rezvan ★★★★★ #55 | Overweight | $25.00→ $28.00+12.0% |
|
Sep 15
13:19 UTC
|
MUR
Murphy Oil
|
◎ Target | Tim Rezvan ★★★★★ #55 | Overweight | $43.00→ $47.00+9.3% |
|
Sep 15
13:19 UTC
|
KRP
Kimbell Royalty
|
◎ Target | Tim Rezvan ★★★★★ #55 | Overweight | $17.00→ $18.00+5.9% |
|
Sep 15
13:19 UTC
|
ENVA
Enova International
|
◎ Target | David Scharf ★★★★☆ #856 | Market Outperform | $270.00→ $215.00-20.4% |
|
Sep 15
13:19 UTC
|
DT
Dynatrace
|
◎ Target | Keith Bachman ★★★★★ #121 | Outperform | $60.00→ $62.00+3.3% |
|
Sep 15
13:19 UTC
|
DFTX
Definium Therapeutics
|
◎ Target | Christopher Chen not yet tracked | Outperform | $75.00→ $79.00+5.3% |
|
Sep 15
13:19 UTC
|
CTNM
Contineum Therapeutics
|
◎ Target | Joel Beatty ★★★☆☆ #1574 | Outperform | $20.00→ $19.00-5.0% |
|
Sep 15
13:19 UTC
|
CLLS
Cellectis
|
◎ Target | Jack Allen ★★★☆☆ #1798 | Outperform | $10.00→ $8.00-20.0% |
|
Sep 15
13:19 UTC
|
CLLS
Cellectis
|
◎ Target | Yanan Zhu ★★★☆☆ #1818 | Equal Weight | $4.00→ $3.00-25.0% |
|
Sep 15
13:19 UTC
|
CAKE
Cheesecake Factory
|
◎ Target | Zachary Fadem ★★★☆☆ #2123 | Equal Weight | $90.00→ $105.00+16.7% |
|
Sep 15
13:19 UTC
|
BWIN
Baldwin Insurance Group
|
◎ Target | Charlie Lederer ★★★★☆ #548 | Market Perform | $26.00→ $32.50+25.0% |
|
Sep 15
13:19 UTC
|
BLKB
Blackbaud
|
◎ Target | Rob Oliver not yet tracked | Outperform | $54.00→ $58.00+7.4% |
|
Sep 15
13:19 UTC
|
BKV
BKV
|
◎ Target | Betty Jiang ★★★☆☆ #1290 | Overweight | $36.00→ $35.00-2.8% |
|
Sep 15
13:19 UTC
|
BBNX
Beta Bionics
|
◎ Target | Jeff Johnson ★★★☆☆ #1722 | Neutral | $14.00→ $16.00+14.3% |
|
Sep 15
13:19 UTC
|
WFG
West Fraser Timber
|
↑ Upgrade | firm only | Market Perform→ Outperform | $85.00 |
|
Sep 15
13:19 UTC
|
THRM
Gentherm
|
↑ Upgrade | Rajat Gupta not yet tracked | Neutral→ Overweight | $48.00 |
|
Sep 15
13:19 UTC
|
SEIC
SEI Investments
|
↑ Upgrade | firm only | Market Perform→ Outperform | |
|
Sep 15
13:19 UTC
|
RLGT
Radiant Logistics
|
↑ Upgrade | Jeff Kauffman ★★★☆☆ #1707 | Market Perform→ Market Outperform | $10.00 |
|
Sep 15
13:19 UTC
|
NYT
New York Times
|
↑ Upgrade | Curry Baker ★★★☆☆ #2030 | Neutral→ Buy | $70.00→ $82.00+17.1% |
|
Sep 15
13:19 UTC
|
MIDD
Middleby
|
↑ Upgrade | Tami Zakaria ★★★☆☆ #1023 | Neutral→ Overweight | $147.00 |
|
Sep 15
13:19 UTC
|
GSK
GSK
|
↑ Upgrade | Kerry Holford ★★★☆☆ #1367 | Hold→ Buy | |
|
Sep 15
13:19 UTC
|
ETSY
Etsy
|
↑ Upgrade | Jason Helfstein ★★☆☆☆ #2229 | Market Perform→ Outperform | $90.00 |
|
Sep 15
13:19 UTC
|
ADNT
Adient
|
↑ Upgrade | Rajat Gupta not yet tracked | Neutral→ Overweight | $25.00 |
|
Sep 15
12:19 UTC
|
ZBRA
Zebra Technologies
|
◎ Target | Robert Jamieson ★★★★☆ #882 | Buy | $410.00→ $435.00+6.1% |
|
Sep 15
12:19 UTC
|
TDY
Teledyne Technologies
|
◎ Target | Robert Jamieson ★★★★☆ #882 | Buy | $750.00→ $760.00+1.3% |
|
Sep 15
12:19 UTC
|
SYM
Symbotic
|
◎ Target | Robert Jamieson ★★★★☆ #882 | Buy | C$75.00→ C$60.00-20.0% |
|
Sep 15
12:19 UTC
|
SRRK
Scholar Rock
|
◎ Target | Andres Y. Maldonado ★★★☆☆ #2172 | Buy | $65.00→ $70.00+7.7% |
|
Sep 15
12:19 UTC
|
SEI
Solaris Energy Infrastructure
|
◎ Target | Sean Milligan ★☆☆☆☆ #3092 | Buy | $98.00→ $104.00+6.1% |
|
Sep 15
12:19 UTC
|
RBLX
Roblox
|
◎ Target | Clark Lampen ★★☆☆☆ #2739 | Sell | $30.00→ $41.00+36.7% |
|
Sep 15
12:19 UTC
|
MTDR
Matador Resources
|
◎ Target | Tim Rezvan ★★★★★ #55 | Overweight | $68.00→ $73.00+7.4% |
|
Sep 15
12:19 UTC
|
EXOD
Exodus Movement
|
◎ Target | Andrew Harte ★★★☆☆ #1342 | Buy | $16.00→ $12.00-25.0% |
|
Sep 15
12:19 UTC
|
EOSE
Eos Energy Enterprises
|
◎ Target | Sean Milligan ★☆☆☆☆ #3092 | Buy | $11.00→ $10.00-9.1% |
|
Sep 15
12:19 UTC
|
ELMT
Elmet Group
|
◎ Target | James Ricchiuti ★★★☆☆ #1471 | Buy | $21.00→ $25.00+19.0% |
|
Sep 15
12:19 UTC
|
PNR
Pentair
|
↑ Upgrade | Nigel Coe ★★☆☆☆ #2305 | Peer Perform→ Outperform | $91.00 |
|
Sep 15
12:19 UTC
|
NYT
New York Times
|
↑ Upgrade | Curry Baker ★★★☆☆ #2030 | Neutral→ Buy | |
|
Sep 15
12:19 UTC
|
EVPL
Everplay Group
|
↑ Upgrade | firm only | Buy | GBX 460 |
|
Sep 15
12:19 UTC
|
CRDF
Cardiff Oncology
|
↑ Upgrade | Robert Burns ★★★☆☆ #1846 | Neutral→ Buy | |
|
Sep 15
12:19 UTC
|
AGL
Agilon Health
|
↑ Upgrade | Lance Wilkes ★★★★★ #206 | Market Perform→ Outperform | $86.00→ $125.00+45.3% |
|
Sep 15
11:19 UTC
|
WPP
WPP
|
◎ Target | firm only | Buy | GBX 405→ GBX 470+16.0% |
|
Sep 15
11:19 UTC
|
WIZZ
Wizz Air
|
◎ Target | firm only | Hold | GBX 1,200→ GBX 1,000-16.7% |
|
Sep 15
11:19 UTC
|
NWG
NatWest Group
|
◎ Target | firm only | Neutral | GBX 790→ GBX 830+5.1% |
|
Sep 15
11:19 UTC
|
LLOY
Lloyds Banking Group
|
◎ Target | firm only | Neutral | GBX 121→ GBX 123+1.7% |
|
Sep 15
11:19 UTC
|
KIST
Kistos
|
◎ Target | firm only | Buy | GBX 325→ GBX 405+24.6% |
|
Sep 15
11:19 UTC
|
GSK
GSK
|
◎ Target | firm only | Hold | GBX 2,000→ GBX 2,200+10.0% |
|
Sep 15
11:19 UTC
|
DATA
GlobalData
|
◎ Target | firm only | Neutral | GBX 110→ GBX 90-18.2% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.